Literature DB >> 32070807

Infectious diseases occurring in the context of substance use disorders: A concise review.

Bhanu Prakash Kolla1, Tyler Oesterle2, Mark Gold3, Frederick Southwick4, Teresa Rummans2.   

Abstract

Prevalence of infectious diseases is substantially higher among patients with substance use disorders (SUD). Factors associated with drug use including sharing needles and injecting supplies, presence of contaminants in drugs and drug use related paraphernalia, risky behaviors associated with drug use, immune suppression secondary to chronic drug use, poverty and homelessness all increase the risk of infections. Persons with SUD have low rates of health care utilization and may miss opportunities for early diagnosis and care of infectious complications of substance use. When infectious diseases are comorbid with drug use, they are associated with substantial morbidity and mortality and result in significant healthcare costs. Patients with SUD may be rescued from an overdose, detoxified or treated for a SUD but facilities and clinicians are often reluctant to assume responsibility for evaluation and treatment of concurrent infectious or medical diseases. Increased screening for these disorders, utilizing vaccinations and other preventative strategies including clean supplies and safe injecting sites and providing comprehensive substance use and infectious disease treatment have the potential to significantly improve patient related outcomes and enhance public health. In this paper we review the prevalence of various common infectious diseases among persons who use drugs, their clinical presentation, mode of transmission, screening and diagnosis. We detail some of the common mechanisms by which persons who use drugs are at increased risk of contracting infections. We also discuss preventive and treatment strategies for infectious diseases occurring in the context of SUD.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug use; HIV; Infections; Infectious diseases; Injecting drug use

Mesh:

Year:  2020        PMID: 32070807     DOI: 10.1016/j.jns.2020.116719

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Comorbid Affective and Substance Use Disorders of Medicaid/Medicare Beneficiaries at an Opioid Treatment Program Serving Small Urban and Rural Communities.

Authors:  Jamey J Lister; Guijin Lee; Jennifer D Ellis; Emily Pasman; Elizabeth Agius; Stella M Resko
Journal:  Front Psychiatry       Date:  2022-05-02       Impact factor: 5.435

2.  Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals' experiences.

Authors:  Siv-Elin Leirvaag Carlsen; Katja Isaksen; Lars Thore Fadnes; Ole Jørgen Scheie Lygren; Anne Nordrehaug Åstrøm
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-05-17

3.  COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out.

Authors:  Meryem Jefferies; Harunor Rashid; Robert Graham; Scott Read; Gouri R Banik; Thao Lam; Gaitan F Njiomegnie; Mohammed Eslam; Xiaojing Zhao; Nausheen Ahmed; Mark W Douglas; Jacob George
Journal:  Vaccines (Basel)       Date:  2022-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.